181 related articles for article (PubMed ID: 27063502)
1. The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.
Chen Q; Xiao X; Wolfe A; Chen XS
J Mol Biol; 2016 Jul; 428(13):2661-70. PubMed ID: 27063502
[TBL] [Abstract][Full Text] [Related]
2. Molecular Interactions of a DNA Modifying Enzyme APOBEC3F Catalytic Domain with a Single-Stranded DNA.
Fang Y; Xiao X; Li SX; Wolfe A; Chen XS
J Mol Biol; 2018 Jan; 430(1):87-101. PubMed ID: 29191651
[TBL] [Abstract][Full Text] [Related]
3. An insight into the dependence of the deamination rate of human APOBEC3F on the length of single-stranded DNA, which is affected by the concentrations of APOBEC3F and single-stranded DNA.
Wan L; Kamba K; Nagata T; Katahira M
Biochim Biophys Acta Gen Subj; 2020 Feb; 1864(2):129346. PubMed ID: 30986508
[TBL] [Abstract][Full Text] [Related]
4. Influence of the DNA sequence/length and pH on deaminase activity, as well as the roles of the amino acid residues around the catalytic center of APOBEC3F.
Wan L; Nagata T; Katahira M
Phys Chem Chem Phys; 2018 Jan; 20(5):3109-3117. PubMed ID: 28825755
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.
Lu X; Zhang T; Xu Z; Liu S; Zhao B; Lan W; Wang C; Ding J; Cao C
J Biol Chem; 2015 Feb; 290(7):4010-21. PubMed ID: 25542899
[TBL] [Abstract][Full Text] [Related]
6. Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure.
McDaniel YZ; Wang D; Love RP; Adolph MB; Mohammadzadeh N; Chelico L; Mansky LM
Nucleic Acids Res; 2020 Feb; 48(3):1353-1371. PubMed ID: 31943071
[TBL] [Abstract][Full Text] [Related]
7. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
[TBL] [Abstract][Full Text] [Related]
8. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.
Fu Y; Ito F; Zhang G; Fernandez B; Yang H; Chen XS
Biochem J; 2015 Oct; 471(1):25-35. PubMed ID: 26195824
[TBL] [Abstract][Full Text] [Related]
9. Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.
Maiti A; Myint W; Delviks-Frankenberry KA; Hou S; Kanai T; Balachandran V; Sierra Rodriguez C; Tripathi R; Kurt Yilmaz N; Pathak VK; Schiffer CA; Matsuo H
J Mol Biol; 2020 Nov; 432(23):6042-6060. PubMed ID: 33098858
[TBL] [Abstract][Full Text] [Related]
10. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
Ito F; Fu Y; Kao SA; Yang H; Chen XS
J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
[TBL] [Abstract][Full Text] [Related]
11. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA; Pathak VK
J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.
Mbisa JL; Bu W; Pathak VK
J Virol; 2010 May; 84(10):5250-9. PubMed ID: 20219927
[TBL] [Abstract][Full Text] [Related]
13. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
[TBL] [Abstract][Full Text] [Related]
15. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
[TBL] [Abstract][Full Text] [Related]
16. Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.
Bohn JA; DaSilva J; Kharytonchyk S; Mercedes M; Vosters J; Telesnitsky A; Hatziioannou T; Smith JL
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578294
[TBL] [Abstract][Full Text] [Related]
17. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1).
Petersen-Mahrt SK; Neuberger MS
J Biol Chem; 2003 May; 278(22):19583-6. PubMed ID: 12697753
[TBL] [Abstract][Full Text] [Related]
18. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores.
Donahue JP; Levinson RT; Sheehan JH; Sutton L; Taylor HE; Meiler J; D'Aquila RT; Song C
J Virol; 2015 Feb; 89(4):2415-24. PubMed ID: 25505075
[TBL] [Abstract][Full Text] [Related]
20. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
Bélanger K; Langlois MA
Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
